Hosted on MSN28d
Genetic tweak to drug-making cells resolves a decades-old challenge in biomanufacturing
Moreover, the cells demonstrated improved growth and, compared to similarly treated controls, produced significantly higher yields of protein-based drugs such as Herceptin and Rituximab ...
Science Daily29d
Genetic tweak optimizes drug-making cells by blocking buildup of toxic byproduct
Moreover, the cells demonstrated improved growth and, compared to similarly treated controls, produced significantly higher yields of protein-based drugs such as Herceptin and Rituximab ...
pharmaphorum2d
FDA approves Herceptin biosimilar as US patent expires
The FDA has approved Amgen and Allergan’s biosimilar of Roche’s Herceptin, just in time for the breast cancer blockbuster’s patent expiry. Herceptin’s main US patent expires this month ...